COVID-19 Pandemic: Impact on Cancer Patients
1. The COVID-19 Pandemic and Associated Changes in Medical Care
2. Impacts of Postponed Cancer Screening, Diagnosis and Treatment
3. COVID-19 in Cancer Patients
4. The Challenges of Post-Pandemic Cancer Care
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- WHO. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available online: https://www.who.int/publications/m/item/summary-of-probable-sars-cases-with-onset-of-illness-from-1-november-2002-to-31-july-2003 (accessed on 20 September 2022).
- WHO. Middle East Respiratory Syndrome. Available online: https://www.emro.who.int/health-topics/mers-cov/mers-outbreaks.html (accessed on 20 September 2022).
- Pederson, T. Where are we, a century after the “Spanish Flu”? FASEB J. 2018, 32, 2317–2318. [Google Scholar] [CrossRef] [PubMed]
- WHO. Coronavirus Disease (COVID-19) Pandemic. Available online: https://www.covid19.who.int (accessed on 20 September 2022).
- Boettcher, A.N.; Hammoud, D.A.; Weinberg, J.B.; Agarwal, P.; Mendiratta-Lala, M.; Luker, G.D. Cancer imaging and patient care during the COVID-19 pandemic. Radiol. Imaging Cancer 2020, 13, e200058. [Google Scholar] [CrossRef] [PubMed]
- Peacock, H.M.; Tambuyzer, T.; Verdoodt, F.; Calay, F.; Poirel, H.A.; De Schutter, H.; Francart, J.; Van Damme, N.; Van Eycken, L. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: A year-long, population-level analysis. ESMO Open 2021, 6, 100197. [Google Scholar] [CrossRef] [PubMed]
- Dinmohamed, A.G.; Visser, O.; Verhoeven, R.H.A.; Louwman, M.W.J.; van Nederveen, F.H.; Willems, S.M.; Merkx, M.A.W.; Lemmens, V.E.P.P.; Nagtegaal, I.D.; Siesling, S. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020, 21, 750–751, Erratum in Lancet Oncol. 2020, 21, e304. [Google Scholar] [CrossRef]
- Greenwood, E.; Swanton, C. Consequences of COVID-19 for cancer care-a CRUK perspective. Nat. Rev. Clin. Oncol. 2021, 18, 3–4. [Google Scholar] [CrossRef]
- Waterhouse, D.M.; Harvey, R.D.; Hurley, P.; Levit, L.A.; Kim, E.S.; Klepin, H.D.; Mileham, K.F.; Nowakowski, G.; Schenkel, C.; Davis, C.; et al. Early Impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: Findings from an American Society of Clinical Oncology Survey. JCO Oncol. Pract. 2020, 16, 417–421. [Google Scholar] [CrossRef]
- Schifferdecker, K.E.; Vaclavik, D.; Wernli, K.J.; Buist, D.S.M.; Kerlikowske, K.; Sprague, B.L.; Henderson, L.M.; Johnson, D.; Budesky, J.; Jackson-Nefertiti, G.; et al. Women’s considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev. Med. 2021, 151, 106542. [Google Scholar] [CrossRef]
- Olszewski, R.; Obiala, J.; Obiala, K.; Manczak, M.; Owoc, J.; Cwiklinska, K.; Jeziorski, K. One year into COVID-19—The epidemiology of cancer screening. Biul. Pol. Tow. Onkol. Nowotw. 2022, 72, 195–199. [Google Scholar] [CrossRef]
- The Lancet Oncology. COVID-19 and the US health insurance conundrum. Lancet Oncol. 2020, 21, 733. [Google Scholar] [CrossRef]
- Andrzejczak, A.; Zarlok, E.; Osowiecka, K.; Rucinska, M. Execution of the breast cancer and cervical cancer screening programs in Poland in the first period of restrictions introduced due to the COVID-19 pandemic. Med. Ogólna Nauk. Zdrowiu 2021, 27, 428–434. [Google Scholar] [CrossRef]
- Koczkodaj, P.; Kaminski, M.F.; Ciuba, A.; Didkowska, J. Cancer screening coverage in Poland-from bad to better to the worst during the SARS-CoV-2 pandemic. Arch. Med. Sci. 2021, 17, 1132–1133. [Google Scholar] [CrossRef] [PubMed]
- de Pelsemaeker, M.C.; Guiot, Y.; Vanderveken, J.; Galant, C.; Van Bockstal, M.R. The impact of the COVID-19 pandemic and the associated Belgian governmental measures on cancer screening, surgical pathology and cytopathology. Pathobiology 2021, 88, 46–55. [Google Scholar] [CrossRef] [PubMed]
- Ilgün, A.S.; Özmen, V. The impact of the COVID-19 pandemic on breast cancer patients. Eur. J. Breast Health 2021, 18, 85–90. [Google Scholar] [CrossRef] [PubMed]
- Toss, A.; Isca, C.; Venturelli, M.; Nasso, C.; Ficarra, G.; Bellelli, V.; Armocida, C.; Barbieri, E.; Cortesi, L.; Moscetti, L.; et al. Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era. ESMO Open 2021, 6, 100055. [Google Scholar] [CrossRef] [PubMed]
- Vanni, G.; Tazzioli, G.; Pellicciaro, M.; Materazzo, M.; Paolo, O.; Cattadori, F.; Combi, F.; Papi, S.; Pistolese, C.A.; Cotesta, M.; et al. Delay in breast cancer treatments during the first COVID-19 lockdown. A multicentric analysis of 432 patients. Anticancer Res. 2020, 40, 7119–7125. [Google Scholar] [CrossRef] [PubMed]
- Yong, J.H.; Mainprize, J.G.; Yaffe, M.J.; Ruan, Y.; Poirier, A.E.; Coldman, A.; Nadeau, C.; Iragorri, N.; Hilsden, R.J.; Brenner, D.R. The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada. J. Med. Screen. 2021, 28, 100–107. [Google Scholar] [CrossRef]
- Vanni, G.; Pellicciaro, M.; Materazzo, M.; Bruno, V.; Oldani, C.; Pistolese, C.A.; Buonomo, C.; Caspi, J.; Gualtieri, P.; Chiaravalloti, A.; et al. Lockdown of breast cancer screening for COVID-19: Possible scenario. In Vivo 2020, 34, 3047–3053. [Google Scholar] [CrossRef]
- Trojanowski, M.; Radomyski, P.; Matuszewski, K.; Litwiniuk, M.; Wierzchosławska, E.; Kycler, W. Impact of the COVID-19 pandemic on breast cancer stage at diagnosis in a regional cancer center in Poland between 2019 and 2021. J. Pers. Med. 2022, 12, 1486. [Google Scholar] [CrossRef]
- Cantini, L.; Mentrasti, G.; Russo, G.L.; Signorelli, D.; Pasello, G.; Rijavec, E.; Russano, M.; Antonuzzo, L.; Rocco, D.; Giusti, R.; et al. Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): Fewer cases and higher stages from a real-world scenario. ESMO Open 2022, 7, 100406. [Google Scholar] [CrossRef]
- Richards, M.A.; Westcombe, A.M.; Love, S.B.; Littlejohns, P.; Ramirez, A. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999, 353, 1119–1126. [Google Scholar] [CrossRef]
- Sud, A.; Torr, B.; Jones, M.E.; Broggio, J.; Scott, S.; Loveday, C.; Garrett, A.; Gronthoud, F.; Nicol, D.L.; Jhanji, S.; et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: A modelling study. Lancet Oncol. 2020, 21, 1035–1044. [Google Scholar] [CrossRef]
- Sharpless, N.E. COVID-19 and cancer. Science 2020, 368, 1290. [Google Scholar] [CrossRef] [PubMed]
- Maringe, C.; Spicer, J.; Morris, M.; Purushotham, A.; Nolte, E.; Sullivan, R.; Rachet, B.; Aggarwal, A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study. Lancet Oncol. 2020, 21, 1023–1034. [Google Scholar] [CrossRef]
- Lai, A.; Pasea, L.; Banerjee, A.; Denaxas, S.; Katsoulis, M.; Chang, W.H.; Williams, B.; Pillay, D.; Noursadeghi, M.; Linch, D.; et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. MedRxiv 2020. [Google Scholar] [CrossRef]
- Hawila, N.; Berg, A. Assessing the impact of COVID-19 on registered interventional clinical trials. Clin. Transl. Sci. 2021, 14, 1147–1154. [Google Scholar] [CrossRef]
- Slotman, B.J.; Lievens, Y.; Poortmans, P.; Cremades, V.; Eichler, T.; Wakefield, D.V.; Ricardi, U. Effect of COVID-19 pandemic on practice in European radiation oncology centers. Radiother. Oncol. 2020, 150, 40–42. [Google Scholar] [CrossRef]
- Slotman, B.J.; Cremades, V.; Kirby, A.M.; Ricardi, U. European radiation oncology after one year of COVID-19 pandemic. Clin. Transl. Radiat. Oncol. 2021, 28, 141–143. [Google Scholar] [CrossRef]
- Wakefield, D.V.; Sanders, T.; Wilson, E.; Hubler, A.; DeWeese, T.; Smith, B.D.; Slotman, B.J.; Sarria, G.R.; Eichler, T.; Schwartz, D.L. Initial impact and operational responses to the COVID-19 pandemic by American Radiation Oncology Practices. Int. J. Radiat. Oncol. Biol. Phys. 2020, 108, 356–361. [Google Scholar] [CrossRef]
- Spencer, K.; Jones, C.M.; Girdler, R.; Roe, C.; Sharpe, M.; Lawton, S.; Miller, L.; Lewis, P.; Evans, M.; Sebag-Montefiore, D.; et al. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: A population-based study. Lancet Oncol. 2021, 22, 309–320. [Google Scholar] [CrossRef]
- Park, C.L.; Russell, B.S.; Fendrich, M.; Finkelstein-Fox, L.; Hutchison, M.; Becker, J. Americans’ COVID-19 stress, coping, and adherence to CDC guidelines. J. Gen. Intern. Med. 2020, 35, 2296–2303. [Google Scholar] [CrossRef]
- Klaassen, Z.; Wallis, C.J.D. Assessing patient risk from cancer and COVID-19: Managing patient distress. Urol. Oncol. 2021, 39, 243–246. [Google Scholar] [CrossRef] [PubMed]
- Romito, F.; Dellino, M.; Loseto, G.; Opinto, G.; Silvestris, E.; Cormio, C.; Guarini, A.; Minoia, C. Psychological distress in outpatients with lymphoma during the COVID-19 pandemic. Front. Oncol. 2020, 10, 1270. [Google Scholar] [CrossRef] [PubMed]
- Ng, D.W.L.; Chan, F.H.F.; Barry, T.J.; Lam, C.; Chong, C.Y.; Kok, H.C.X.; Liao, Q.; Fielding, R.; Lam, W.W.T. Psychological distress during the 2019 coronavirus disease (COVID-19) pandemic among cancer survivors and healthy controls. Psychooncology 2020, 29, 1380–1383. [Google Scholar] [CrossRef] [PubMed]
- Lee, K.A.; Ma, W.; Sikavi, D.R.; Drew, D.A.; Nguyen, L.H.; Bowyer, R.C.E.; Cardoso, M.J.; Fall, T.; Freidin, M.B.; Gomez, M.; et al. COPE consortium. Cancer and risk of COVID-19 through a general community survey. Oncologist 2021, 26, e182185. [Google Scholar] [CrossRef]
- Liu, C.; Zhao, Y.; Okwan-Duodu, D.; Basho, R.; Cui, X. COVID-19 in cancer patients: Risk, clinical features, and management. Cancer Biol. Med. 2020, 17, 519–527. [Google Scholar] [CrossRef]
- ElGohary, G.M.; Hashmi, S.; Styczynski, J.; Kharfan-Dabaja, M.A.; Alblooshi, R.M.; de la Cámara, R.; Mohmed, H.; Alshaibanii, A.; Cesaroj, S.; El-Aziz, N.A.; et al. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol. Oncol. Stem Cell Ther. 2020, 30, S1658–S3876. [Google Scholar] [CrossRef]
- Dai, M.; Liu, D.; Liu, M.; Zhou, F.; Li, G.; Chen, Z.; Zhang, Z.; You, H.; Wu, M.; Zheng, Q.; et al. Patients with cancer appear more vulnerable to SARS-COV-2: A multicenter study during the COVID-19 outbreak. Cancer Discov. 2020, 10, 783–791. [Google Scholar] [CrossRef]
- Kuderer, N.M.; Choueiri, T.K.; Shah, D.P.; Shyr, Y.; Rubinstein, S.M.; Rivera, D.R.; Shete, S.; Hsu, C.-Y.; Desai, A.; Lopes, G.L., Jr.; et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet 2020, 395, 1907–1918. [Google Scholar] [CrossRef]
- Lee, L.Y.W.; Cazier, J.B.; Starkey, T.; Arnold, R.; Bisht, V.; Campton, N.A.; Chackathayil, J.; Cheng, V.W.T.; Curley, H.M.; Fittall, M.W.; et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study. Lancet 2020, 395, 1919–1926. [Google Scholar] [CrossRef]
- Liang, W.; Guan, W.; Chen, R.; Wang, W.; Li, J.; Xu, K.; Li, C.; Ai, Q.; Lu, W.; Liang, H.; et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020, 21, 335–337. [Google Scholar] [CrossRef]
- Zhang, L.; Zhu, F.; Xie, L.; Wang, C.; Wang, J.; Chen, R.; Jia, P.; Guan, H.Q.; Peng, L.; Chen, Y.; et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann. Oncol. 2020, 31, 894–901. [Google Scholar] [CrossRef] [PubMed]
- Vuagnat, P.; Frelaut, M.; Ramtohul, T.; Basse, C.; Diakite, S.; Noret, A.; Bellesoeur, A.; Servois, W.; Hequet, D.; Laas, E.; et al. COVID-19 in breast cancer patients: A cohort at the institute curie hospitals in the Paris area. Breast Cancer Res. 2020, 22, 55. [Google Scholar] [CrossRef] [PubMed]
- van de Haar, J.; Hoes, L.R.; Coles, C.E.; Seamon, K.; Fröhling, S.; Jäger, D.; Valenza, F.; de Braud, F.; De Petris, L.; Bergh, J.; et al. Caring for patients with cancer in the COVID-19 era. Nat. Med. 2020, 26, 665–671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- NCCN. Available online: https://www.nccn.org/docs/default-source/covid-19/2021-covid-self-care-stress-management-patients-caregivers-english.pdf?sfvrsn=3b4ae89d_5 (accessed on 20 September 2022).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rucinska, M.; Nawrocki, S. COVID-19 Pandemic: Impact on Cancer Patients. Int. J. Environ. Res. Public Health 2022, 19, 12470. https://doi.org/10.3390/ijerph191912470
Rucinska M, Nawrocki S. COVID-19 Pandemic: Impact on Cancer Patients. International Journal of Environmental Research and Public Health. 2022; 19(19):12470. https://doi.org/10.3390/ijerph191912470
Chicago/Turabian StyleRucinska, Monika, and Sergiusz Nawrocki. 2022. "COVID-19 Pandemic: Impact on Cancer Patients" International Journal of Environmental Research and Public Health 19, no. 19: 12470. https://doi.org/10.3390/ijerph191912470